Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
Why the Market Dipped But Astrazeneca (AZN) Gained Today
07:34pm, Thursday, 04'th Jan 2024
Astrazeneca (AZN) reachead $68.78 at the closing of the latest trading day, reflecting a +0.67% change compared to its last close.
7 Dividend-Paying Stocks To Add To Your Income Portfolio In 2024
01:43pm, Wednesday, 03'rd Jan 2024
I believe that 2024 will be good for equities. Potential rate cuts are a big impending catalyst.
GSK gets shot in arm from upgrade, AstraZeneca mixed reviews after China deal
06:36am, Wednesday, 03'rd Jan 2024
GSK PLC (LSE:GSK, NYSE:GSK) shares got a shot in the arm this morning after Jefferies took a more positive view of the pharmaceuticals giant. The US investment bank upgraded its rating to ‘buy' fr
C4X Discovery receives $11m AstraZeneca milestone payment
02:33am, Wednesday, 03'rd Jan 2024
C4X Discovery Holdings PLC (AIM:C4XD) has reached what has been described as a "significant milestone" after receiving an $11 million payment under its $402 million deal with pharma giant AstraZeneca
AstraZeneca, Sanofi's RSV infant shots approved in China
02:13am, Tuesday, 02'nd Jan 2024
AstraZeneca and Sanofi's respiratory syncytial virus (RSV) immunization for infants has been approved in China, the London-listed drugmaker said on Tuesday.
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note
07:33pm, Friday, 29'th Dec 2023
Astrazeneca (AZN) closed the most recent trading day at $67.35, moving +0.07% from the previous trading session.
Astrazeneca (AZN) Surpasses Market Returns: Some Facts Worth Knowing
07:32pm, Wednesday, 27'th Dec 2023
In the most recent trading session, Astrazeneca (AZN) closed at $67.35, indicating a +1.28% shift from the previous trading day.
AstraZeneca (AZN) Set to Acquire Gracell for $1.2 Billion
12:01pm, Wednesday, 27'th Dec 2023
AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion.
AstraZeneca PLC (AZN) is Attracting Investor Attention: Here is What You Should Know
10:31am, Wednesday, 27'th Dec 2023
Astrazeneca (AZN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AstraZeneca to buy Chinese drug firm in billion dollar deal
02:41am, Wednesday, 27'th Dec 2023
AstraZeneca PLC (LSE:AZN) is set to acquire Gracell Biotechnologies, the Chinese company specialising in innovative cancer and autoimmune disease treatments, for US$1.2 billion The US$2 per share ac
Yes Virginia, There Is a Santa Claus Rally
06:47pm, Tuesday, 26'th Dec 2023
The Russell is up an astounding +26% from late October, largely thanks to signaled interest rate cuts from the Fed in 2024.
Acquisitions Push 2 Pharma Stocks in Opposite Directions
10:24am, Tuesday, 26'th Dec 2023
Pharmaceutical giants AstraZeneca plc (NASDAQ:AZN) and Bristol-Myers Squibb Co (NYSE:BMY) announced new acquisitions today.
AstraZeneca to Acquire China's Gracell in $1.2 Billion Deal to Further Cell Therapy Goals
05:37am, Tuesday, 26'th Dec 2023
AstraZeneca's acquisition of Gracell is expected to close in the first quarter of 2024.
These 3 Big Pharma Stocks Are Making Big Plays With AI
07:15am, Friday, 22'nd Dec 2023
Big drug companies want to use artificial intelligence for a handful of purposes. Finding leads to make medicines more efficiently is one in-demand application.
Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment
08:43pm, Thursday, 21'st Dec 2023
Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca's AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of a rare genetic disease.
